Health AI Central
Share:
Peer-Reviewed Publication
Pathology2024;56(2):205-213.March 1, 2024Journal Article

Predictive and prognostic biomarkers in gastrointestinal tract tumours.

Klaudia M Nowak1, Runjan Chetty2
1Laboratory Medicine Program, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada. Electronic address: klaudia.nowak@uhn.ca.
2Diagnexia, Exeter, United Kingdom.
PubMed DOI

Abstract

Tumours of the gastrointestinal tract represent nearly a quarter of all newly diagnosed tumours diagnosed in 2019. Various treatment modalities for gastrointestinal cancers exist, some of which may be guided by biomarkers. Biomarkers act as gauges of either normal or pathogenic processes or responses to an exposure or intervention. They come in many forms. This review explores established and pote…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.